{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:22:08Z","timestamp":1783225328666,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Reversal of activated hepatic stellate cells (HSCs) to a quiescent state and apoptosis of activated HSCs are key elements in the reversion of hepatic fibrosis. CCAAT\/enhancer binding protein \u03b1 (C\/EBP-\u03b1) has been shown to inhibit HSC activation and promote its apoptosis. This study aims to investigate how C\/EBP-\u03b1 acetylation affects the fate of activated HSCs. Effects of a histone deacetylation inhibitor trichostatin A (TSA) on HSC activation were evaluated in a mouse model of liver fibrosis caused by carbon tetrachloride (CCl<jats:sub>4<\/jats:sub>) intoxication. TSA was found to ameliorate CCl<jats:sub>4<\/jats:sub>-induced hepatic fibrosis and improve liver function through increasing the protein level and enhancing C\/EBP-\u03b1 acetylation in the mouse liver. C\/EBP-\u03b1 acetylation was determined in HSC lines in the presence or absence of TSA, and the lysine residue K276 was identified as a main acetylation site in C\/EBP-\u03b1 protein. C\/EBP-\u03b1 acetylation increased its stability and protein level, and inhibited HSC activation. The present study demonstrated that C\/EBP-\u03b1 acetylation increases the protein level by inhibiting its ubiquitination-mediated degradation, and may be involved in the fate of activated HSCs. Use of TSA may confer an option in minimizing hepatic fibrosis by suppressing HSC activation, a key process in the initiation and progression of hepatic fibrosis.<\/jats:p>","DOI":"10.1038\/s41598-018-22662-6","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T09:59:55Z","timestamp":1520416795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Trichostatin A inhibits the activation of Hepatic stellate cells by Increasing C\/EBP-\u03b1 Acetylation in vivo and in vitro"],"prefix":"10.1038","volume":"8","author":[{"given":"Di","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Zhen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Jian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Han","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-7364","authenticated-orcid":false,"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"key":"22662_CR1","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1128\/MCB.00049-13","volume":"33","author":"KH Kim","year":"2013","unstructured":"Kim, K. H., Chen, C. C., Monzon, R. I. & Lau, L. F. Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts. Mol Cell Biol 33, 2078 (2013).","journal-title":"Mol Cell Biol"},{"key":"22662_CR2","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/qjmed\/hcs069","volume":"105","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran, P. & Iredale, J. P. Liver fibrosis: a bidirectional model of fibrogenesis and resolution. Qjm 105, 813 (2012).","journal-title":"Qjm"},{"key":"22662_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/gut.48.4.548","volume":"48","author":"R Issa","year":"2001","unstructured":"Issa, R. et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 48, 548 (2001).","journal-title":"Gut"},{"key":"22662_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1053\/j.gastro.2012.06.036","volume":"143","author":"JS Troeger","year":"2012","unstructured":"Troeger, J. S., Mederacke, I., Gwak, G. Y., Dapito, D. H. & Mu, X. Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice. Gastroenterology 143, 1073 (2012).","journal-title":"Gastroenterology"},{"key":"22662_CR5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.bbrc.2004.09.196","volume":"324","author":"G Huang","year":"2004","unstructured":"Huang, G., Zhang, J. & Tang, Q. Involvement of C\/EBP-\u03b1 gene in in vitro activation of rat hepatic stellate cells. Biochem Bioph Res Co 324, 1309 (2004).","journal-title":"Biochem Bioph Res Co"},{"key":"22662_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbrc.2009.01.060","volume":"380","author":"X Wang","year":"2009","unstructured":"Wang, X. et al. Over-expression of C\/EBP-\u03b1 induces apoptosis in cultured rat hepatic stellate cells depending on p53 and peroxisome proliferator-activated receptor-\u03b3. Biochem Bioph Res Co 380, 286 (2009).","journal-title":"Biochem Bioph Res Co"},{"key":"22662_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1872-034X.2007.00074.x","volume":"37","author":"S Mei","year":"2007","unstructured":"Mei, S., Wang, X., Zhang, J., Qian, J. & Ji, J. In vivo transfection of C\/EBP-\u03b1 gene could ameliorate CCL4 -induced hepatic fibrosis in mice. Hepatol Res 37, 531 (2007).","journal-title":"Hepatol Res"},{"key":"22662_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s10495-012-0700-y","volume":"17","author":"L Tao","year":"2012","unstructured":"Tao, L. et al. C\/EBP-\u03b1 ameliorates CCl4-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo. Apoptosis 17, 492 (2012).","journal-title":"Apoptosis"},{"key":"22662_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/leu.2010.222","volume":"25","author":"TC Lin","year":"2011","unstructured":"Lin, T. C. et al. CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia. LEUKEMIA 25, 32 (2011).","journal-title":"LEUKEMIA"},{"key":"22662_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jmoldx.2011.05.002","volume":"13","author":"T Lin","year":"2011","unstructured":"Lin, T. et al. Rapid Assessment of the Heterogeneous Methylation Status of CEBPA in Patients with Acute Myeloid Leukemia by Using High-Resolution Melting Profile. The Journal of Molecular Diagnostics 13, 514 (2011).","journal-title":"The Journal of Molecular Diagnostics"},{"key":"22662_CR11","doi-asserted-by":"publisher","first-page":"e38841","DOI":"10.1371\/journal.pone.0038841","volume":"7","author":"MS Hasemann","year":"2012","unstructured":"Hasemann, M. S. et al. Phosphorylation of serine 248 of C\/EBP alpha is dispensable for myelopoiesis but its disruption leads to a low penetrant myeloid disorder with long latency. Plos One 7, e38841 (2012).","journal-title":"Plos One"},{"key":"22662_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.120","volume":"4","author":"P Pal","year":"2013","unstructured":"Pal, P. et al. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C\/EBP \u03b1 for ubiquitin-mediated proteasome degradation. Cell Death and Disease 4, e590 (2013).","journal-title":"Cell Death and Disease"},{"key":"22662_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.mce.2008.03.009","volume":"289","author":"ATI Cese","year":"2008","unstructured":"Cese, A. T. I. et al. Acetylation and deacetylation regulate CCAAT\/enhancer binding protein \u03b2 at K39 in mediating gene transcription. Mol Cell Endocrinol 289, 94 (2008).","journal-title":"Mol Cell Endocrinol"},{"key":"22662_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","volume":"90","author":"W Gu","year":"1997","unstructured":"Gu, W. & Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595 (1997).","journal-title":"Cell"},{"key":"22662_CR15","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1101\/gad.12.18.2831","volume":"12","author":"K Sakaguchi","year":"1998","unstructured":"Sakaguchi, K. et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12, 2831 (1998).","journal-title":"Genes Dev"},{"key":"22662_CR16","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1128\/MCB.19.2.1202","volume":"19","author":"Lin Liu","year":"1999","unstructured":"Lin Liu et al. p53 Sites Acetylated In Vitro by PCAF and p300 Are Acetylated In Vivo in Response to DNA Damage. Mol Cell Biol 19, 1202 (1999).","journal-title":"Mol Cell Biol"},{"key":"22662_CR17","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1128\/MCB.19.5.3496","volume":"19","author":"HL Hung","year":"1999","unstructured":"Hung, H. L., Lau, J., Kim, A. Y., Weiss, M. J. & Blobel, G. A. CREB-Binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Molecular & Cellular Biology 19, 3496 (1999).","journal-title":"Molecular & Cellular Biology"},{"key":"22662_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1097-2765(04)00094-2","volume":"13","author":"HY Cohen","year":"2004","unstructured":"Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B. & Imahiyerobo, T. A. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13, 627 (2004).","journal-title":"Mol Cell"},{"key":"22662_CR19","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S1097-2765(01)00272-6","volume":"7","author":"S Hasan","year":"2001","unstructured":"Hasan, S., Stucki, M., Hassa, P. O., Imhof, R. & Gehrig, P. Regulation of Human Flap Endonuclease-1 Activity by Acetylation through the Transcriptional Coactivator p300. Mol Cell 7, 1221 (2001).","journal-title":"Mol Cell"},{"key":"22662_CR20","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00702-012-0786-y","volume":"119","author":"H Wang","year":"2012","unstructured":"Wang, H., Cheng, H., Wang, K. & Wen, T. Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells. J Neural Transm 119, 1307 (2012).","journal-title":"J Neural Transm"},{"key":"22662_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","volume":"5","author":"M Dokmanovic","year":"2007","unstructured":"Dokmanovic, M., Clarke, C. & Marks, P. A. Histone Deacetylase Inhibitors: Overview and Perspectives. Mol Cancer Res 5, 981 (2007).","journal-title":"Mol Cancer Res"},{"key":"22662_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2004.10.001","volume":"40","author":"C Monneret","year":"2005","unstructured":"Monneret, C. Histone deacetylase inhibitors. Eur J Med Chem 40, 1 (2005).","journal-title":"Eur J Med Chem"},{"key":"22662_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1309\/42D6-W7PL-FX0A-LBXF","volume":"113","author":"KG Ishak","year":"2000","unstructured":"Ishak, K. G. Pathologic features of chronic hepatitis. Am J Clin Pathol 113, 40 (2000).","journal-title":"Am J Clin Pathol"},{"key":"22662_CR24","doi-asserted-by":"crossref","unstructured":"Elsharkawy, A. M., Oakley, F. & Mann, D. A. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 10, 927 (2005).","DOI":"10.1007\/s10495-005-1055-4"},{"key":"22662_CR25","first-page":"G709","volume":"300","author":"JA Fallowfield","year":"2011","unstructured":"Fallowfield, J. A. Therapeutic targets in liver fibrosis. AJP: Gastrointestinal and Liver Physiology 300, G709 (2011).","journal-title":"AJP: Gastrointestinal and Liver Physiology"},{"key":"22662_CR26","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/emboj\/19.4.662","volume":"19","author":"MA Martinez-Balbas","year":"2000","unstructured":"Martinez-Balbas, M. A., Bauer, U. M., Nielsen, S. J., Brehm, A. & Kouzarides, T. Regulation of E2F1 activity by acetylation. Embo J 19, 662 (2000).","journal-title":"Embo J"},{"key":"22662_CR27","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1128\/MCB.21.7.2413-2422.2001","volume":"21","author":"W Zhang","year":"2001","unstructured":"Zhang, W., Kadam, S., Emerson, B. M. & Bieker, J. J. Site-Specific Acetylation by p300 or CREB Binding Protein Regulates Erythroid Kruppel-Like Factor Transcriptional Activity via Its Interaction with the SWI-SNF Complex. Molecular & Cellular Biology 21, 2413 (2001).","journal-title":"Molecular & Cellular Biology"},{"key":"22662_CR28","doi-asserted-by":"crossref","unstructured":"Bararia, D. et al. Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C\/EBP-\u03b1. pp. 22 800 (2008).","DOI":"10.1038\/sj.leu.2405101"},{"key":"22662_CR29","doi-asserted-by":"publisher","first-page":"e57013","DOI":"10.1371\/journal.pone.0057013","volume":"8","author":"A Sato","year":"2013","unstructured":"Sato, A., Yamada, N., Ogawa, Y. & Ikegami, M. CCAAT\/Enhancer-Binding Protein-\u03b1 Suppresses Lung Tumor Development in Mice through the p38a MAP Kinase Pathway. Plos One 8, e57013 (2013).","journal-title":"Plos One"},{"key":"22662_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/jnci\/djj093","volume":"98","author":"Y Tada","year":"2006","unstructured":"Tada, Y. et al. Epigenetic Modulation of Tumor Suppressor CCAAT\/Enhancer Binding Protein \u03b1 Activity in Lung Cancer. JNCI Journal of the National Cancer Institute 98, 396 (2006).","journal-title":"JNCI Journal of the National Cancer Institute"},{"key":"22662_CR31","first-page":"273","volume":"44","author":"J Lekstrom-Himes","year":"1998","unstructured":"Lekstrom-Himes, J. & Xanthopoulos, K. G. Biological role of the CCAAT\/enhancer-binding protein family of transcription factors. J Biol Chem 44, 273 (1998).","journal-title":"J Biol Chem"},{"key":"22662_CR32","doi-asserted-by":"crossref","unstructured":"Ramji, D. P. & Foka, P. CCAAT\/enhancer-binding protein: structure, function and regulation. Biochem J Pt 3365 (2002).","DOI":"10.1042\/bj20020508"},{"key":"22662_CR33","first-page":"1766","volume":"1","author":"MB Schuster","year":"2006","unstructured":"Schuster, M. B. & Porse, B. T. C\/EBP-alpha: a tumour suppressor in multiple tissues? Biochim Biophys Acta 1, 1766 (2006).","journal-title":"Biochim Biophys Acta"},{"key":"22662_CR34","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.3892\/mmr.2017.7358","volume":"16","author":"L Tao","year":"2017","unstructured":"Tao, L. et al. TSA increases C\/EBP-\u03b1 expression by increasing its lysine acetylation in hepatic stellate cells. Mol Med Rep 16, 6088 (2017).","journal-title":"Mol Med Rep"},{"key":"22662_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/hep.1840150211","volume":"15","author":"SL Friedman","year":"1992","unstructured":"Friedman, S. L. et al. Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 15, 234 (1992).","journal-title":"Hepatology"},{"key":"22662_CR36","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/hep.25650","volume":"56","author":"J Ji","year":"2012","unstructured":"Ji, J. et al. Comparative proteomic analysis of rat hepatic stellate cell activation: a comprehensive view and suppressed immune response. Hepatology 56, 332 (2012).","journal-title":"Hepatology"},{"key":"22662_CR37","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.510290328","volume":"29","author":"T Niki","year":"1999","unstructured":"Niki, T. et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 29, 858 (1999).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22662-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22662-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22662-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:17:28Z","timestamp":1671592648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22662-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22662"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22662-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"5 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4395"}}